SCHEMBL16319805

SCHEMBL16319805

O=S(=O)(Nc1cc[c]c(NC2CCCCC2)c1)c1ccccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.38
LMNA P02545 3/20 0.37
ALDH1A1 P00352 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
GLO1 Q04760 3/20 0.37
SLC40A1 Q9NP59 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP17A1 P05093 1/20 0.36
TSHR P16473 1/20 0.36
GPR39 O43194 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
EGFR P00533 1/20 0.34
ERBB2 P04626 1/20 0.34
MET P08581 1/20 0.34
KDR P35968 1/20 0.34
MERTK Q12866 1/20 0.34
NLRP3 Q96P20 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16320203 0.77 ALDH1A1 (0.48) LMNAALDH1A1GAAMAPK1
SCHEMBL16319954 0.74 PTGS2 (0.48) MAPK1
SCHEMBL5609641 0.71 GLO1 (0.50) GRM4GLO1SLC40A1KDM4ECYP17A1
SCHEMBL5610166 0.70 GLO1 (0.49) GLO1SLC40A1KDM4EL3MBTL1
SCHEMBL8164647 0.67 GLO1 (0.55) GRM4ALDH1A1GLO1SLC40A1KDM4E
SCHEMBL16320125 0.67 PKM (0.45) LMNAALDH1A1KDM4EHSD17B10MEN1
SCHEMBL25391392 0.65 GLO1 (0.47) GLO1SLC40A1CYP17A1L3MBTL1
SCHEMBL19512927 0.65 HPGD (0.51) LMNAALDH1A1GLO1SLC40A1GAA
SCHEMBL5609697 0.65 GLO1 (0.47) GRM4GLO1SLC40A1KDM4ECYP17A1
SCHEMBL8515156 0.65 PFKFB3 (0.65) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2544684-B1 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES USEFUL AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-1 (DPP-1) JANSSEN PHARMACEUTICA NV (BE) 2014-12-24 EP disclosed